Navigation

    REAN Foundation

    • Register
    • Login
    • Search
    • Categories
    • Unread
    • Recent
    • Tags
    • Popular
    • Admin

    Could a Type 2 Diabetes Drug Tackle Kidney Stones?

    Chronic Conditions
    2
    2
    1
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • R
      Rajkamal last edited by

      Patients with type 2 diabetes who received empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, were almost 40% less likely to have a kidney stone than patients who received placebo during a median 1.5 years of treatment. These findings are from an analysis of pooled data from phase 1-4 clinical trials of empagliflozin for blood glucose control in 15,081 patients with type 2 diabetes.

      M 1 Reply Last reply Reply Quote 0
      • M
        Malkeet Singh @Rajkamal last edited by

        @rajkamal Dedicated randomized prospective clinical trials are needed to confirm these initial observations in patients both with and without type 2 diabetes

        1 Reply Last reply Reply Quote 0
        • First post
          Last post